Search results
Novartis AG (NYSE:NVS) Shares Sold by Cannell & Co.
ETF DAILY NEWS· 2 days agoCannell & Co. trimmed its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 19.2% in the 4th quarter, according to the company in its most recent 13F filing with ...
Novartis further entrenches into radiopharma with $1B Mariana buy
FierceBiotech· 3 days agoWith much still to discover in the massive world of radiopharmaceuticals, Novartis will take a deep...
Novartis to buy radiology specialist Mariana Oncology for $1 billion
Reuters· 3 days agoNovartis has entered an agreement to acquire US radiopharmaceutical company Mariana Oncology for $1...
Novartis to Buy Mariana Oncology, Paying $1 Billion Upfront
Bloomberg· 3 days agoNovartis agreed to buy US biotech Mariana Oncology Inc. to strengthen its pipeline of drugs that can...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 4 days agoNovartis AG (NYSE:NVS) is one of the largest pharmaceutical companies in the world, many of whose drugs are "gold standards" in the treatment of cancer,...
Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech
Market Watch· 3 days agoPharmaceutical giant Novartis AG on Thursday said it will pay up to $1.75 billion for a U.S. biotech...
Why selling to Novartis made sense for Mariana
BioPharma Dive via Yahoo Finance· 2 days agoRead in an interview. “The business development deals in the run-up to J.P. Morgan had really conditioned the marketplace.” One of those conversations...
Novartis to buy Mariana Oncology in radiopharmaceutical expansion
BioPharma Dive via Yahoo Finance· 3 days agoDive Brief: Novartis is expanding its pipeline of radiopharmaceutical drugs, announcing Thursday it...
Novartis pays PeptiDream $180M as radiopharma big bang continues
FierceBiotech· 5 days agoNovartis is pumping another $180 million into its radioligand plan, handing the cash to serial dealmaker PeptiDream to expand (PDF) a peptide-drug conjugate (PDC) collaboration ...
Novartis to Buy Mariana Oncology for Up to $1.75 Billion in Boost to Radioligand Therapy Business
Morningstar· 3 days agoBy Mauro Orru Novartis agreed to acquire U.S. biotechnology company Mariana Oncology for up to $1.75 billion, in a deal that bolsters its radioligand therapy pipeline and ...
